ACC Cardiology Hour With Dr. Valentin Fuster | ACC.22 Day 1

(37:9)

ACC 22 Late-breaker Discussion: The PROMPT-HF Trial | with Dr Harriette Van Spall

(15:39)

ACC 22: Results from the EMPULSE Study - Empagliflozin Proves Beneficial for Patients with HF

(5:36)

ACC 22: 4 Lipid Late-breaker Highlights from ACC.22 with Dr Erin Michos

(7:10)

ACC 22: Findings From the PARTITA Trial | Dr Paolo Della Bella

(6:31)

ACC 22 Late-breaker Discussion: The DIAMOND Trial | with Dr Harriette Van Spall

(22:48)

Day 1 Highlights | ACC.22

(12:57)

ACC 22: APOLLO FIH Study to Investigate siRNA in Raised Lipoprotein(a) | Dr Steven E Nissen

(3:32)

Butter chicken! India's national dish acc. to NRI's 🤭 #butterchicken #naan #ashortaday #indianfood

(1:)

ACC 22 Late-breaker Discussion: The SODIUM-HF Trial | with Dr Harriette Van Spall

(16:43)

ACC 22: Results from the POISE-3 Trial | Dr Philip J Devereaux

(4:23)

ACC 22: Findings from the ADAPT-TAVR Trial | Dr Duk-Woo Park

(7:45)

Countdown to ACC.22 in Washington DC

(1:26)

ACC 22 Late-breaker Discussion: The SuperWIN Trial | with Dr Harriette Van Spall

(16:58)

View from the Thoraxcenter: ACC.22 Late-breaking Science Wrap-Up

(28:7)

ACC 22: FFR vs. IVUS-guided PCI in Intermediate Coronary Artery Stenosis: The FLAVOUR Trial | Dr Koo

(9:28)

Day 2 Highlights | ACC.22

(14:22)

ACC 22: FAME 3 Suggests CABG Outperforms FFR-Guided PCI in Patients with Multivessel Disease

(3:7)

ACC.22 Opening Showcase Session | Messages from Around the Globe

(3:6)

ACC 22: Results from a sub-study of the POISE-3 Trial | Dr Maura Marcucci

(4:49)